Blue Water Acquisition III - Unit. (BLUWU) vs Voyager Therapeutics (VYGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Blue Water Acquisition III - Unit. (BLUWU) has outperformed Voyager Therapeutics (VYGR) over the past year, gaining 4.7% versus a loss of 55.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLUWU | VYGR |
|---|---|---|
| Share price | $10.50 | $2.37 |
| Market cap | — | $146.03M |
| 1-day change | 0.00% | -4.05% |
| YTD return | -0.47% | -39.69% |
| 1-year return | +4.69% | -55.11% |
| 5-year return | — | -42.20% |
| EPS (TTM) | — | $-1.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.85 | $5.55 |
| 52-week low | $10.03 | $2.33 |
| Distance from 52-week high | -18.29% | -57.30% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +528.27% |
| Average volume | 48 | 573.14K |
| Shares outstanding | — | 61.62M |
| Employees | — | 141 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BLUWU has outperformed VYGR by 59.8 percentage points over the past year.
About Voyager Therapeutics
VYGR stock →Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 141 employees
BLUWU vs VYGR FAQ
Which stock has performed better over the past year, BLUWU or VYGR?
BLUWU returned +4.69% over the past 12 months, compared with -55.11% for VYGR (price return, excluding dividends). Past performance does not predict future results.
Are Blue Water Acquisition III - Unit. and Voyager Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.